Ruxin Medical Systems Co., Ltd.

Ruxin Medical Systems Co., Ltd. was founded in 2013, located in Beijing, China. Ruxin is an innovation-oriented company of researching, manufacturing and supplying medical devices and solutions in the field of airway management and respiratory management globally.We focus on airway clearance technologies and products, also involving in relevant fields of mechanical ventilation. Our current products and those in development includes but not limited, innovative automatic respiratory clearance system (CougSync100), noninvasive suction system (CoughSync800), turbine ventilator (AgiVent300), and ventilation-suction combined system (SucVent series).Ruxin will continue to develop our medical device technologies, providing advanced and reliable products to our customers, improving patients quality of life, and bringing more benefits to a larger part of humanity.Our Vison Better Breathing to Better Life CareCoughSync is a unique innovation in the world. Ruxin is the first company providing it and opening the door for a new market segment of ICU. The first model of CoughSync series is CoughSync100EU In-line Exsufflator, specifically designed for ICU invasively ventilated patients to remove secretions automatically and noninvasively without interrupting the normal working of ICU ventilators. This feature brings important benefits to patients, medical staff, hospital and even the government due to the potentially great expense decrease which is caused by shortened ICU stay and VAP control. Furthermore, the values of the CoughSync100EU for fighting covid-19 are at least as follows:1) Reducing the workload of airway care for ICU staff while reducing their risk of infection;2) The only physical method promising to solve the problem of secretion clearance in the deep lung, reducing or preventing the formation of sputum plugs in distal small airways, of critically ill COVID-19 patients;3) Minimize the number of times of manual catheter suction to reduce the risk of complications caused by airway trauma, while reduce greatly patients pain. And CoughSync provide higher efficacy comparing to catheter suction due to the capability to remove secretions retention in far end of both lungs. For these two reasons, the invasive ventilation time of the patient is expected to be shorten, thus more efficient treatment could be achievable. So, it can also be expected to relieve the current tension situation of intensive care unit (ICU) resources, especially the shortage of ICU ventilators.